Internal Medicine, Cardiovascular Disease · Houston, TX
NPI
1467451856
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5115 Fannin St Ste 801
Houston, TX, 77004
Phone (713) 790-0841
Groups this clinician bills Medicare through
Medicare paid, 2024
$827K
5,096 services
Medicare patients, 2024
490
Average age 76
Drug cost, 2024
$925K
9,407 prescriptions
Company payments, 2025
$797
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert G Hust was code J2785 (injection, regadenoson, 0.1 mg), 1,088 times for 267 patients. In total Robert G Hust billed 5,096 services in 62 codes, and Medicare paid $827K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,088 | 267 | $4.79 | $5,211 |
| 99214 Office E&M - Established | Office | 714 | 386 | $87.27 | $62K |
| 99233 Hospital E&M - Subsequent | Facility | 560 | 48 | $93.06 | $52K |
| 93000 Electrocardiogram | Office | 379 | 294 | $9.30 | $3,525 |
| 93306 Echocardiography (TTE/TEE) | Office | 350 | 327 | $132.37 | $46K |
| 93015 Electrocardiogram | Office | 315 | 307 | $51.09 | $16K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 200 | 193 | $616.19 | $123K |
| 78431 Myocardial Perfusion Scan | Office | 197 | 193 | $1,851.21 | $365K |
| 78452 Myocardial Perfusion Scan | Office | 118 | 117 | $336.96 | $40K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 116 | 112 | $69.14 | $8,021 |
| 93010 Electrocardiogram | Facility | 111 | 61 | $6.37 | $707 |
| 99454 E&M - Miscellaneous | Office | 96 | 13 | $32.93 | $3,161 |
| 93294 External Electrocardiographic Monitoring | Office | 94 | 31 | $22.20 | $2,087 |
| 93297 External Electrocardiographic Monitoring | Office | 92 | 12 | $19.60 | $1,803 |
| 99457 E&M - Miscellaneous | Office | 89 | 13 | $34.65 | $3,084 |
By year: 2022 $820K for 5,951 services; 2023 $774K for 5,813 services; 2024 $827K for 5,096 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert G Hust prescribed most often to Medicare patients was Amlodipine Besylate, with 489 prescriptions and refills. In total Robert G Hust wrote 9,407 Medicare prescriptions that cost $925K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 489 | 1,367 | 142 | $4,456 |
| Losartan Potassium Generic | 446 | 1,252 | 127 | $6,162 |
| Ezetimibe Generic | 426 | 1,176 | 123 | $11K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 406 | 1,112 | 117 | $11K |
| Metoprolol Succinate Generic | 400 | 1,102 | 110 | $7,630 |
| Clopidogrel Clopidogrel Bisulfate | 400 | 1,132 | 115 | $5,101 |
| Rosuvastatin Calcium Generic | 354 | 1,011 | 99 | $4,459 |
| Furosemide Generic | 345 | 931 | 107 | $2,623 |
| Metoprolol Tartrate Generic | 343 | 939 | 107 | $2,953 |
| Eliquis Apixaban | 332 | 590 | 68 | $328K |
| Atorvastatin Calcium Generic | 322 | 890 | 93 | $2,918 |
| Lisinopril Generic | 291 | 743 | 81 | $4,198 |
| Pantoprazole Sodium Generic | 215 | 541 | 54 | $3,905 |
| Pravastatin Sodium Generic | 203 | 500 | 49 | $2,346 |
| Levothyroxine Sodium Generic | 191 | 536 | 53 | $2,599 |
Brand drugs: - claims; generic drugs: 8,421 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert G Hust $797 ($797 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novartis Pharmaceuticals Corporation with $219.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $219 |
| Abbott Laboratories ABT | 7 | $140 |
| Esperion Therapeutics, Inc. ESPR | 5 | $80.03 |
| Medtronic, Inc. MDT | 1 | $74.54 |
| Novo Nordisk Inc NVO | 3 | $71.25 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $61.79 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $47.4 |
| Amgen Inc. AMGN | 2 | $37.15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33.96 |
| GlaxoSmithKline, LLC. GSK | 1 | $17.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.